Search research articles
Contact Us
Filters
Showing results (151-160 of 226) with videos related to
Page
of 23
Sort By:
Molecular Cancer Research : MCR
|
October 8, 2009
The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors
Jin Kyung Rho, Yun Jung Choi, Jin Kyung Lee, et al.
Stem Cells and Development
|
September 19, 2014
Epigenetic activation of the Foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion
So-Young Bang, So Hee Kwon, Sang-Hoon Yi, et al.
Pancreas
|
February 15, 2017
Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines
Dae Wook Hwang, Kwang Sup So, Song Cheol Kim, et al.
Clinical Lung Cancer
|
August 29, 2018
Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
In-Jae Oh, Jae Young Hur, Cheol-Kyu Park, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation
Jin Kyung Rho, Yun Jung Choi, Byung-Suk Jeon, et al.
Oncotarget
|
September 24, 2017
Multiple receptor tyrosine kinase activation related to ALK inhibitor resistance in lung cancer cells with ALK rearrangement
Se Hoon Choi, Dong Ha Kim, Yun Jung Choi, et al.
Journal of Korean Medical Science
|
December 17, 2003
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow
Min Jong Kang, Yeon-Mok Oh, Jae Cheol Lee, et al.
Targeted Oncology
|
April 15, 2020
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Yong-Hee Cho, Myeong Geun Choi, Dong Ha Kim, et al.
Plos One
|
December 9, 2014
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M
Kwang Sup So, Cheol Hyeon Kim, Jin Kyung Rho, et al.
International Journal of Clinical and Experimental Pathology
|
November 18, 2014
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer
Ho-Cheol Kim, Joon Seon Song, Jae Cheol Lee, et al.
Page
of 23
Search research articles
Search
Showing results (151-160 of 226) with videos related to
Sort By:
Page
of 23
Molecular Cancer Research : MCR
|
October 8, 2009
The role of MET activation in determining the sensitivity to epidermal growth factor receptor tyrosine kinase inhibitors
Jin Kyung Rho, Yun Jung Choi, Jin Kyung Lee, et al.
Stem Cells and Development
|
September 19, 2014
Epigenetic activation of the Foxa2 gene is required for maintaining the potential of neural precursor cells to differentiate into dopaminergic neurons after expansion
So-Young Bang, So Hee Kwon, Sang-Hoon Yi, et al.
Pancreas
|
February 15, 2017
Autophagy Induced by CX-4945, a Casein Kinase 2 Inhibitor, Enhances Apoptosis in Pancreatic Cancer Cell Lines
Dae Wook Hwang, Kwang Sup So, Song Cheol Kim, et al.
Clinical Lung Cancer
|
August 29, 2018
Clinical Activity of Pan-HER Inhibitors Against HER2-Mutant Lung Adenocarcinoma
In-Jae Oh, Jae Young Hur, Cheol-Kyu Park, et al.
Molecular Cancer Therapeutics
|
December 17, 2010
Combined treatment with silibinin and epidermal growth factor receptor tyrosine kinase inhibitors overcomes drug resistance caused by T790M mutation
Jin Kyung Rho, Yun Jung Choi, Byung-Suk Jeon, et al.
Oncotarget
|
September 24, 2017
Multiple receptor tyrosine kinase activation related to ALK inhibitor resistance in lung cancer cells with ALK rearrangement
Se Hoon Choi, Dong Ha Kim, Yun Jung Choi, et al.
Journal of Korean Medical Science
|
December 17, 2003
Lung matrix metalloproteinase-9 correlates with cigarette smoking and obstruction of airflow
Min Jong Kang, Yeon-Mok Oh, Jae Cheol Lee, et al.
Targeted Oncology
|
April 15, 2020
Natural Killer Cells as a Potential Biomarker for Predicting Immunotherapy Efficacy in Patients with Non-Small Cell Lung Cancer
Yong-Hee Cho, Myeong Geun Choi, Dong Ha Kim, et al.
Plos One
|
December 9, 2014
Autophagosome-mediated EGFR down-regulation induced by the CK2 inhibitor enhances the efficacy of EGFR-TKI on EGFR-mutant lung cancer cells with resistance by T790M
Kwang Sup So, Cheol Hyeon Kim, Jin Kyung Rho, et al.
International Journal of Clinical and Experimental Pathology
|
November 18, 2014
Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer
Ho-Cheol Kim, Joon Seon Song, Jae Cheol Lee, et al.
Page
of 23